Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002040066 | SCV002108716 | pathogenic | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1352951). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Gln927*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Gene |
RCV002040066 | SCV003805758 | likely pathogenic | not provided | 2022-04-15 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Genome- |
RCV003451986 | SCV004182398 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003451985 | SCV004182399 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003451986 | SCV004208347 | pathogenic | Retinitis pigmentosa 39 | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Ophthalmo- |
RCV002307769 | SCV002600234 | pathogenic | Usher syndrome type 2 | 2022-11-14 | no assertion criteria provided | clinical testing | Novel pathogenic variant. PVS1, PM2, PP5, PP4, PM3. |